Overview
Upper limb hypertrophy is a rare congenital condition in which one or both arms or hands are noticeably larger than normal. This overgrowth can involve the bones, muscles, fat, skin, or a combination of these tissues in the upper limbs. The condition is typically present at birth or becomes apparent during early childhood as the affected limb grows disproportionately compared to the rest of the body. It falls under the broader category of limb overgrowth disorders. People with upper limb hypertrophy may notice that one arm or hand is significantly bigger than the other, which can affect grip strength, fine motor skills, and the ability to perform everyday tasks. The degree of enlargement varies widely — some individuals have mild asymmetry while others experience substantial size differences that can impact function and appearance. In some cases, the overgrowth may be part of a broader overgrowth syndrome affecting other parts of the body. Treatment is generally tailored to the individual and focuses on improving function and appearance. Options may include physical therapy, occupational therapy, orthopedic interventions, and in some cases surgery to reduce the size of the affected limb or correct skeletal abnormalities. There is currently no single cure, and management is typically supportive and multidisciplinary. Early evaluation by specialists can help guide the best approach for each patient.
Key symptoms:
One arm or hand noticeably larger than the otherIncreased length of the affected armIncreased girth or thickness of the affected arm or handEnlarged fingers on the affected sideAsymmetry between the two upper limbsDifficulty with fine motor tasks like writing or buttoning clothesReduced range of motion in the affected limbSoft tissue swelling in the arm or handBone overgrowth visible on X-rayCosmetic concerns about limb appearancePossible vascular abnormalities in the affected limb
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
FDA & Trial Timeline
6 eventsBristol-Myers Squibb
Bristol-Myers Squibb — PHASE4
Bayer — PHASE3
Paulista University — NA
SuZhou Sinus Medical Technologies Co.,Ltd — NA
Bristol-Myers Squibb — PHASE4
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Upper limb hypertrophy.
1 clinical trialare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Upper limb hypertrophy.
Community
No community posts yet. Be the first to share your experience with Upper limb hypertrophy.
Start the conversation →Latest news about Upper limb hypertrophy
Disease timeline:
New recruiting trial: A Study of Mavacamten in Adults With Obstructive Hypertrophic Cardiomyopathy in India (ROVER)
A new clinical trial is recruiting patients for Upper limb hypertrophy
New recruiting trial: TANGO-LIVER Three Arm Nuclear Growth Observation in Liver Surgery
A new clinical trial is recruiting patients for Upper limb hypertrophy
New recruiting trial: A Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopathy in China
A new clinical trial is recruiting patients for Upper limb hypertrophy
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What is causing the overgrowth in my child's arm, and could it be part of a genetic syndrome?,Should we pursue genetic testing, and if so, what type of testing is recommended?,How likely is the size difference to increase as my child grows?,What treatment options are available, and when is surgery recommended?,Are there any targeted medications, like alpelisib, that might be appropriate for our situation?,What therapies can help improve hand function and daily activities?,How often should we schedule follow-up visits to monitor the condition?
Common questions about Upper limb hypertrophy
What is Upper limb hypertrophy?
Upper limb hypertrophy is a rare congenital condition in which one or both arms or hands are noticeably larger than normal. This overgrowth can involve the bones, muscles, fat, skin, or a combination of these tissues in the upper limbs. The condition is typically present at birth or becomes apparent during early childhood as the affected limb grows disproportionately compared to the rest of the body. It falls under the broader category of limb overgrowth disorders. People with upper limb hypertrophy may notice that one arm or hand is significantly bigger than the other, which can affect grip
At what age does Upper limb hypertrophy typically begin?
Typical onset of Upper limb hypertrophy is neonatal. Age of onset can vary across affected individuals.
Are there clinical trials for Upper limb hypertrophy?
Yes — 1 recruiting clinical trial is currently listed for Upper limb hypertrophy on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Upper limb hypertrophy?
6 specialists and care centers treating Upper limb hypertrophy are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.